Claim Missing Document
Check
Articles

Found 2 Documents
Search

HUBUNGAN POSISI MENERAN DENGAN LAMA KALA DUA PERSALINAN Istiqamah; Khairul Anami; Iwan Yuwindry
Midwifery And Complementary Care Vol 2 No 1 (2023): Midwifery and Complementary Care
Publisher : LPPM Universitas Sari Mulia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33859/mcc.v2i1.602

Abstract

Background: The second stage of labor, also known as the expulsion stage, occurs when the baby's head stretches the vaginal tissues. The physiological process of the second stage of labor refers to a series of events that occur during this period, ending with the normal delivery of the baby. One aspect of respectful maternity care during labor is allowing the mother to choose her preferred pushing and birthing position. Allowing this choice can provide many benefits, including reduced pain and discomfort. Objective: To analyze the relationship between pushing position and the duration of the second stage of labor at TPMB Istiqamah Banjarmasin. Methods: This study used an analytical survey method with a cross-sectional approach. The sample consisted of 35 women in the second stage of labor at TPMB Istiqamah Banjarmasin. Results: The Chi-square test yielded a p-value of 0.005 (<0.05), indicating that the null hypothesis was rejected and the alternative hypothesis was accepted. This suggests a significant relationship between pushing position and the duration of the second stage of labor. The results showed that the lateral pushing position was more effective during the second stage of labor. Conclusion: There is a significant relationship between pushing position and the duration of the second stage of labor. The lateral pushing position was found to be more effective due to various factors that influence labor progression, including the passage, power, passenger, and labor position. Keywords: Second Stage of Labor, Laboring Mothers, Pushing Position
Study of the Impact of Side Effects of Using Off-Label Drugs in Patients with Systemic Lupus Erythematosus on Health Costs Iwan Yuwindry; Yusri; Hansel Hens Tangkas
Journal of Advances in Medicine and Pharmaceutical Sciences Vol 2 No 2: November 2023
Publisher : Lamintang Education and Training Centre, in collaboration with the International Association of Educators, Scientists, Technologists, and Engineers (IA-ESTE)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36079/lamintang.jamaps-0202.529

Abstract

The main problem in conducting lupus treatment is that most drugs for the therapy provided have not been authorized so that they are still included in the class of off-label drugs for the treatment of lupus. The use of off-label drugs can carry the potential for side effects in Lupus patients which have an impact on increasing health costs. This study aims to determine the impact of side effects of using off-label drugs on health costs in lupus patients, as an integrated evaluation in seeking to improve the quality of life and ensure proper care in Lupus patients. This study was conducted using a cross-sectional method by means of a survey using the Naranjo Algorithm instrument (PESO Book) to determine the incidence rate of side effects that exist in LSE therapy using off-label drugs and calculate the health costs of lupus patients. The results showed that the most respondents were in adulthood (19 respondents or 47.5%), then the most respondents were female (37 respondents or 92.5%). Data on the incidence of side effects obtained the most respondents in the Probable category (most likely to occur ROM) of 14 respondents or 35%. In addition, data on health costs incurred by more respondents experienced an increase, namely 23 respondents or 57.5%. The research data shows the calculated r value is 0.3044 and the Sig (2-tailed) value is 0.000 with a confidence level (CI) of 0.05. The results of the analysis clearly show that there is a significant relationship between the side effects of using off-label drugs on the health costs of lupus patients, in this correlation there is a unidirectional relationship, where if the value of side effects experienced by respondents is high, the value of respondents' health costs is also high.